You Searched For "bharat biotech covid vaccine" and got 20 results
Sort By:
2 mins read
Pan-India rollout of U-WIN to track routine immunisations likely by Aug end
The U-WIN platform captures every vaccination event for pregnant women and children under the Unive…
PTI
2 mins read
BHU study on Covaxin side effects poorly designed, critically flawed: ICMR Director General
The Indian Council of Medical Research Director General Dr Rajiv Bahl has criticised a recently pub…
PTI
1 min read
Bharat Biotech's intranasal Covid vaccine approved by govt, to be available on CO-WIN
Prime Minister Narendra Modi had on Thursday cautioned people against complacency and urged…
PTI
2 mins read
Biological E, Bharat Biotech together sitting on stockpile of 250 million COVID vaccine doses
stockpile of 50 million doses of Covaxin. Dr Vikram Paradkar, Executive Vice President (M…
PTI
3 mins read
A 68-year-old cofounded a biotech business instead of retiring. He's not getting paid for his work but values staying 'mentally engaged.'
Michael McCaman, 70, cofounded a biotech company in 2022 instead of retiring. He's not on payroll,…
John Towfighi
2 mins read
Bharat Biotech's nasal Covid vaccine to be priced at ₹800 for private and ₹325 for govt hospitals
Bharat Biotech's nasal COVID-19 vaccine iNCOVACC, which was given approval as a booster dose, will …
ANI
2 mins read
Ideal time for COVID-19 booster shot is six months after the second dose, says Bharat Biotech MD
"The ideal time for a booster dose is six months after the second dose," Ella stated. Abo…
PTI
2 mins read
WHO approves Bharat Biotech’s Covaxin for emergency use after a long wait
The WHO, in a tweet, said: "WHO has granted emergency use listing (EUL) to Covaxin, developed by…
4 mins read
Supreme Court wants the Indian government to explain vaccine pricing — and clarify how many doses it will need as coverage expands from May 1
The Supreme Court of India has decided it cannot be a “mute spectator” as the number of new COVID-1…
2 mins read
Bharat Biotech’s Covaxin shows 81% efficacy after second dose in phase 3 trials
Hyderabad-based Bharat Biotech released phase 3 results of its Covid-19 vaccine — Covaxin — today. …
3 mins read
Covaxin supply to government at ₹150 per dose is not sustainable, says Bharat Biotech
The supply price of Covaxin to the government of India at Rs 150 a dose is a non-competitive price …
3 mins read
Rivals Serum Institute and Bharat Biotech come together after fear of ban on vaccine exports
Bharat Biotech CEO Krishna Ella and Serum Institute of India (SII) CEO Adar Poonawalla issued a joi…
4 mins read
OPINION: No matter what Bharat Biotech says, Covaxin is just not ready for approvals
Benefits like how effective the vaccine is in preventing disease, and risks such as high morta…
1 min read
After Serum Institute of India, Bharat Biotech says it will reduce the cost of COVAXIN for state governments
Bharat Biotech, the company behind the COVID-19 vaccine COVAXIN, has slashed the price of its vacci…
1 min read
Germany to recognise Bharat Biotech’s 'Covaxin' from June 1
In a tweet, Lindner said, Very happy that GER government just decided to recognize WHO-listed Covax…
2 mins read
Bharat Biotech's COVID-19 vaccine COVAXIN is well tolerated with no serious adverse events as per phase 1 trial results
A preprint is a version of a scientific manuscript posted on a public server prior to formal pe…
PTI
4 mins read
Bharat Biotech sees rivals’ conspiracy in all the criticism for the approval for Covaxin
Bharat Biotech chairman and managing director, Krishna Ella, believes that the gossip-mongering …
1 min read
The Indian government is doling out ₹1500 crore to reserve 300 million of Biological-E’s COVID-19 vaccine doses
In a bid to meet the increasing demand for the Coronavirus vaccine, the Indian government is shelli…
1 min read
CAT admit card 2020 to be released today. Here’s how to download
The Indian Institute of Management (IIM), Indore is likely to release the admit card for Common Adm…
8 mins read
COVID-19 vaccine updates in India: Oxford’s COVID-19 vaccine trials can be over by December, if SII doesn’t go for emergency licence
Scientists are still looking for a cure for the deadly coronavirus, which has infected millions of …